Literature DB >> 12413851

Synthesis and evaluation of anticancer benzoxazoles and benzimidazoles related to UK-1.

Devinder Kumar1, Melissa R Jacob, Michael B Reynolds, Sean M Kerwin.   

Abstract

UK-1 is a structurally unique bis(benzoxazole) natural product isolated from a strain of Streptomyces. UK-1 has been reported to possess anticancer activity but no activity against bacteria, yeast, or fungi. Previous work has also demonstrated the ability of UK-1 to bind a variety of di- and tri-valent metal ions, particularly Mg(2+) ions, and to form complexes with double-stranded DNA in the presence of Mg(2+) ions. Here we report the activity of UK-1 against a wide range of human cancer cell lines. UK-1 displays a wide spectrum of potent anticancer activity against leukemia, lymphoma, and certain solid tumor-derived cell lines, with IC(50) values as low as 20 nM, but is inactive against Staphylococcus aureus, a methicillin-resistant strain of S. aureus, or Pseudomonas aeruginosa. A series of analogues of the bis(benzoxazole) natural product UK-1 in which the carbomethoxy-substituted benzoxazole ring of the natural product was modified were prepared and evaluated for their anticancer and antibacterial properties. An analogue of UK-1 in which the carbomethoxy-substituted benzoxazole ring was replaced with a carbomethoxy-substituted benzimidazole ring was inactive against human cancer cell lines and the two strains of S. aureus. In contrast, a simplified analogue in which the carbomethoxy-substituted benzoxazole ring was replaced with a carbomethoxy group was almost as active as UK-1 against the four cancer cell lines examined but lacked activity against S. aureus. Metal ion binding studies of these analogues demonstrate that they both bind Zn(2+) and Ca(2+) ions about as well as UK-1. The non-cytotoxic benzimidazole UK-1 analogue binds Mg(2+) ions 50-fold weaker than UK-1, whereas the simple benzoxazole analogue binds Mg(2+) ions nearly as well as UK-1. These results support a role of Mg(2+) ion binding in the selective cytotoxicity of UK-1 and provide a minimal pharmacophore for the selective cytotoxic activity of the natural product.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12413851     DOI: 10.1016/s0968-0896(02)00327-9

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  20 in total

1.  Synthesis, metal ion binding, and biological evaluation of new anticancer 2-(2'-hydroxyphenyl)benzoxazole analogs of UK-1.

Authors:  Mireya L McKee; Sean M Kerwin
Journal:  Bioorg Med Chem       Date:  2007-11-12       Impact factor: 3.641

2.  Evaluation of complexes of DNA duplexes and novel benzoxazoles or benzimidazoles by electrospray ionization mass spectrometry.

Authors:  Leon Oehlers; Carolyn L Mazzitelli; Jennifer S Brodbelt; Mireya Rodriguez; Sean Kerwin
Journal:  J Am Soc Mass Spectrom       Date:  2004-11       Impact factor: 3.109

3.  Synthesis and In-Vivo Evaluation of Benzoxazole Derivatives as Promising Anti-Psoriatic Drugs for Clinical Use.

Authors:  Rami Ayoub; Jamal Jilani; Qais Jarrar; Raad Alani; Chrismawan Ardianto; Khang Wen Goh; Dalia Ali; Said Moshawih
Journal:  Molecules       Date:  2022-05-08       Impact factor: 4.927

4.  UK-1 and structural analogs are potent inhibitors of hepatitis C virus replication.

Authors:  Dawn N Ward; Daniel C Talley; Mrinalini Tavag; Samrawit Menji; Paul Schaughency; Andrea Baier; Paul J Smith
Journal:  Bioorg Med Chem Lett       Date:  2013-12-09       Impact factor: 2.823

5.  Diversity-oriented synthesis of benzimidazole, benzoxazole, benzothiazole and quinazolin-4(3H)-one libraries via potassium persulfate-CuSO4-mediated oxidative coupling reactions of aldehydes in aqueous micelles.

Authors:  Atul Kumar; Ram Awatar Maurya; Deepti Saxena
Journal:  Mol Divers       Date:  2009-07-04       Impact factor: 2.943

6.  Synthesis of novel benzimidazolyl-substituted acrylonitriles and amidino-substituted benzimidazo[1,2-a]quinolines.

Authors:  Marijana Hranjec; Grace Karminski-Zamola
Journal:  Molecules       Date:  2006-08-13       Impact factor: 4.411

Review 7.  Metastasis review: from bench to bedside.

Authors:  Ali Mohammad Alizadeh; Sadaf Shiri; Sadaf Farsinejad
Journal:  Tumour Biol       Date:  2014-08-08

8.  Evaluation of metal-mediated DNA binding of benzoxazole ligands by electrospray ionization mass spectrometry.

Authors:  Carolyn L Mazzitelli; Mireya Rodriguez; Sean M Kerwin; Jennifer S Brodbelt
Journal:  J Am Soc Mass Spectrom       Date:  2007-05-23       Impact factor: 3.109

9.  Design, synthesis and structural studies of meta-xylyl linked bis-benzimidazolium salts: potential anticancer agents against 'human colon cancer'.

Authors:  Rosenani A Haque; Muhammad Adnan Iqbal; Mohamed B Khadeer Ahamed; Ams Abdul Majid; Zena A Abdul Hameed
Journal:  Chem Cent J       Date:  2012-07-18       Impact factor: 4.215

10.  Benzimidazole and Benzoxazole Zinc Chelators as Inhibitors of Metallo-β-Lactamase NDM-1.

Authors:  Abigail C Jackson; Tyler B J Pinter; Daniel C Talley; Adnan Baker-Agha; Dhruvil Patel; Paul J Smith; Katherine J Franz
Journal:  ChemMedChem       Date:  2020-11-19       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.